The Endless Question of Opioid Doses for Breakthrough Pain
DOI: 10.1634/THEONCOLOGIST.2020-0312
关键词:
摘要: This letter to the editor responds comments in still open debate regarding use of breakthrough pain medications cancer patients.
sci-hub.st 参考文章(12)
Sebastiano Mercadante, Patrizia Villari, Patrizia Ferrera, Mauro Bianchi, Alessandra Casuccio, Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose Journal of Pain and Symptom Management. ,vol. 27, pp. 352- 359 ,(2004) , 10.1016/J.JPAINSYMMAN.2003.09.006
Sebastiano Mercadante, Giuseppe Intravaia, Patrizia Villari, Patrizia Ferrera, Salvatore Riina, Salvatore Mangione, Intravenous Morphine for Breakthrough (Episodic-) Pain in an Acute Palliative Care Unit: A Confirmatory Study Journal of Pain and Symptom Management. ,vol. 35, pp. 307- 313 ,(2008) , 10.1016/J.JPAINSYMMAN.2007.04.018
G W Hanks, F de Conno, N Cherny, M Hanna, E Kalso, H J McQuay, S Mercadante, J Meynadier, P Poulain, C Ripamonti, L Radbruch, J Roca i Casas, J Sawe, R G Twycross, V Ventafridda, Morphine and alternative opioids in cancer pain : the EAPC recommendations British Journal of Cancer. ,vol. 84, pp. 587- 593 ,(2001) , 10.1054/BJOC.2001.1680
Sebastiano Mercadante, Intravenous morphine for management of cancer pain. Lancet Oncology. ,vol. 11, pp. 484- 489 ,(2010) , 10.1016/S1470-2045(09)70350-X
Sebastiano Mercadante, The use of rapid onset opioids for breakthrough cancer pain: The challenge of its dosing Critical Reviews in Oncology Hematology. ,vol. 80, pp. 460- 465 ,(2011) , 10.1016/J.CRITREVONC.2010.12.002
Sebastiano Mercadante, Russell K. Portenoy, Breakthrough cancer pain: twenty-five years of study. Pain. ,vol. 157, pp. 2657- 2663 ,(2016) , 10.1097/J.PAIN.0000000000000721
Sebastiano Mercadante, Non pharmacological interventions and non-fentanyl pharmacological treatments for breakthrough cancer pain: A systematic and critical review Critical Reviews in Oncology Hematology. ,vol. 122, pp. 60- 63 ,(2018) , 10.1016/J.CRITREVONC.2017.12.016
Ahsan Azhar, Yu Jung Kim, Ali Haider, David Hui, Vishidha R. Balankari, Margeaux Chiou Epner, Minjeong Park, Diane D. Liu, Janet Williams, Susan E. Frisbee‐Hume, Julio A. Allo, Eduardo Bruera, Response to Oral Immediate‐Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain Oncologist. ,vol. 24, pp. 125- 131 ,(2019) , 10.1634/THEONCOLOGIST.2017-0583
Sebastiano Mercadante, Claudio Adile, Francesco Masedu, Paolo Marchetti, Andrea Costanzi, Federica Aielli, Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study. European Journal of Pain. ,vol. 23, pp. 719- 726 ,(2019) , 10.1002/EJP.1339
Sebastiano Mercadante, Augusto Caraceni, Francesco Masedu, Teresa Scipioni, Federica Aielli, Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain. Oncologist. ,vol. 25, pp. 156- 160 ,(2020) , 10.1634/THEONCOLOGIST.2019-0542